[ Cardior Pharmaceuticals raises $16.31M in Series A ]

Cardior Pharmaceuticals has raised $16.31 million in Series A funding led by Bristol-Myers Squibb, Life Sciences Partners, High-Tech Gruenderfonds and BioMedPartners.

Founded in 2016, Cardior Pharmaceuticals focuses on developing non-coding Ribonucleic acid-based therapeutics for the treatment and prevention of heart diseases.

The company will use the new financing  to continue to advance its therapeutics.

Funding  Series A
Founded  2016
Country  Germany
City  Hannover, Saxony
Founder / CEO  Claudia Ulbrich
Deal Size  $16.31M
Investors  Bristol-Myers Squibb
 Life Sciences Partners
 High-Tech Gruenderfonds
Previous Investors  /